Apoptosis regulators and responses in human melanocytic and keratinocytic cells

Journal of Investigative Dermatology

Volumn 120, Issue 1, 2003, Pages 48-55

  Bowen, Anneli R ^a   Hanks, Adrianne N ^b   Allen, Sarah M ^b   Alexander, April ^a,b   Diedrich, Miyoung J ^b   Grossman, Douglas ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

4 tert butylphenol; Bcl 2; FLIP; Keratinocyte, melanocyte; Melanoma; Survivin; Ultraviolet

Indexed keywords

4 TERT BUTYLPHENOL; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CISPLATIN; ETOPOSIDE; FLICE INHIBITORY PROTEIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN C IAP 1; PROTEIN C IAP 2; PROTEIN LIVIN; PROTEIN MCL 1; PROTEIN P53; STAUROSPORINE; SURVIVIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; ULTRAVIOLET B RADIATION;

EID: 0037244772     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12010.x     Document Type: Article

References (49)

1. Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326, 1998.
2. Alanko T, Rosenberg M, Saksela O: FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 113:111-116, 1999
3. Ashhab Y, Alian A, Polliack A, Panet A, Yehuda DB: Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495:56-60, 2001
4. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 281:1305-1308, 1998
5. Cerroni L, Soyer HP, Kerl H: bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am J Dermatopathol 17:7-11, 1995
6. Collins KA, White WL: Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma. Am J Dermatopathol 17:429-438, 1995
7. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348, 2001
8. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542, 1994
9. Gilchrest BA, Eller MS, Geller AC, Yaar M: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348, 1999
10. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ: Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 115:185-193, 1997
11. Green DR, Reed JC: Mitochondria and apoptosis. Science 281:1309-1312, 1998
12. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ: Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840, 1998
13. Grossman D, Altieri DC: Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 20:3-11, 2001
14. Grossman D, Leffell DJ: The molecular basis of nonmelanoma skin cancer. Arch Dermatol 133:1263-1270, 1997
15. Grossman D, McNiff JM, Li F, Altieri DC: Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113:1076-1081, 1999a
16. Grossman D, McNiff JM, Li F, Altieri DC: Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121-1126, 1999b
17. Irmler M, Thome M, Hahne M, et al: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
18. Ishida-Yamamoto A, Tanaka H, Nakane H, Takahashi H, Hashimoto Y, Iizuka H: Programmed cell death in normal epidermis and loricrin keratoderma. Multiple functions of profilaggrin in keratinization. J Invest Dermatol Symp Proc 4:145-149, 1999
19. Jost M, Gasparro FP, Jensen PJ, Rodeck U: Keratinocyte apoptosis induced by ultraviolet B radiation and CD95 ligation - differential protection through epidermal growth factor receptor activation and Bcl-x(L) expression. J Invest Dermatol 116:860-866, 2001
20. Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276:3238-3246, 2001
21. Kim YG, Kim HJ, Kim DS, et al: Up-regulation and redistribution of Bax in ultraviolet B-irradiated melanocytes. Pigment Cell Res 13:352-357, 2000
22. Koh HK: Cutaneous melanoma. N Engl J Med 325:171-182, 1991
23. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247-3259, 1998
24. Le Poole IC, Yang F, Brown TL, Cornelius J, Babcock GF, Das PK, Boissy RE: Altered gene expression in melanocytes exposed to 4-tertiary butyl phenol (4-TBP). upregulation of the A2b adenosine receptor 1. J Invest Dermatol 113:725-731, 1999
25. Lehman TA, Modali R, Boukamp P, et al: p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-839, 1993
26. Leiter U, Schmid RM, Kaskel P, Peter RU, Krahn G: Anti-apoptotic bcl-2 and bcl-xL in advanced malignant melanoma. Arch Dermatol Res 292:225-232, 2000
27. Li G, Tang L, Zhou X, Tron V, Ho V: Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res 8:17-23, 1998
28. McGuire J, Hendee J: Biochemical basis for depigmentation of skin by phenolic germicides. J Invest Dermatol 57:256-261, 1971
29. Mooney EE, Ruis Peris JM, O'Neill A, Sweeney EC: Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48:242-244, 1995
30. Morales-Ducret CR, van de Rijn M, Smoller BR: bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol 131:915-918, 1995
31. O'Connor DS, Grossman D, Plescia J, et al: Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97:13103-13107, 2000
32. Olie RA, Hafner C, Kuttel R, et al: Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages. J Invest Dermatol 118:505-512, 2002
33. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR: Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn 199:176-188, 1994
34. Raisova M, Hossini AM, Eberle J, et al: The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117:333-340, 2001
35. Satyamoorthy K, Bogenrieder T, Herlyn M: No longer a molecular black box - new clues to apoptosis and drug resistance in melanoma. Trends Mol Med 7:191-194, 2001
36. Selzer E, Schlagbauer-Wadl H, Okamoto I, Pehamberger H, Potter R, Jansen B: Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res 8:197-203, 1998
37. Soengas MS, Capodieci P, Polsky D, et al: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207-211, 2001
38. Staunton MJ, Gaffney EF: Tumor type is a determinant of susceptibility to apoptosis.Am J Clin Pathol 103:300-307, 1995
39. Tang L, Tron VA, Reed JC, et al: Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 4:1865-1871, 1998
40. Thomas WD, Hersey P: TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 161:2195-2200, 1998
41. Ugurel S, Seiter S, Rappl G, Stark A, TilgenW, Reinhold U: Heterogeneous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-X expression and is sensitive to modulation by interferon-gamma. Int J Cancer 82:727-736, 1999
42. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.Curr Biol 10:1359-1366, 2000
43. Weil M, Raff MC, Braga VM: Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 9:361-364, 1999
44. van den Wijngaard RM, Aten J, Scheepmaker A, Le Poole IC, Tigges AJ, Westerhof W, Das PK: Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br J Dermatol 143:573-581, 2000
45. Yamashita T, Tokino T, Tonoki H, Moriuchi T, Jin HY, Omori F, Jimbow K: Induction of apoptosis in melanoma cell lines by p53 and its related proteins. J Invest Dermatol 117:914-919, 2001
46. Yang F, Sarangarajan R, Le Poole IC, Medrano EE, Boissy RE: The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol 114:157-164, 2000
47. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P: Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res 61:7339-7348, 2001
48. Ziegler A, Jonason AS, Leffell DJ, et al: Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994
49. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413, 1997